 | • レポートコード：D0GIR-01203 • 出版社/出版日：GlobalInfoResearch / 2020年9月23日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、B細胞性非ホジキンリンパ腫（NHL）治療の世界市場を広く調査・分析し、今後の市場展望をまとめております。B細胞性非ホジキンリンパ腫（NHL）治療の種類別市場規模（化学療法、放射線療法、その他）、用途別市場規模（病院、クリニック、外来手術センター、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Amgen、Novartis、Merck Serono、Bayer、AbbVie、Bristol-Myers Squibb、AstraZeneca、Roche ・地域別グローバル市場分析 2015年-2020年 ・B細胞性非ホジキンリンパ腫（NHL）治療の北米市場（アメリカ、カナダ、メキシコ） ・B細胞性非ホジキンリンパ腫（NHL）治療のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・B細胞性非ホジキンリンパ腫（NHL）治療のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・B細胞性非ホジキンリンパ腫（NHL）治療の南米市場（ブラジル、アルゼンチン） ・B細胞性非ホジキンリンパ腫（NHL）治療の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：化学療法、放射線療法、その他 ・用途別分析：病院、クリニック、外来手術センター、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The B-Cell Non-Hodgkin’s Lymphoma (NHL) Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The most likely (base case) scenario is that the global B-Cell Non-Hodgkin’s Lymphoma (NHL) Treatment sales will be xx in 2020 from B-Cell Non-Hodgkin’s Lymphoma (NHL) Treatment million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global B-Cell Non-Hodgkin’s Lymphoma (NHL) Treatment market size is expected to grow at xx% or more annually for the next five years.
This report also researches and evaluates the impact of Covid-19 outbreak on the B-Cell Non-Hodgkin’s Lymphoma (NHL) Treatment industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on B-Cell Non-Hodgkin’s Lymphoma (NHL) Treatment and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Market segmentation
B-Cell Non-Hodgkin’s Lymphoma (NHL) Treatment market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, B-Cell Non-Hodgkin’s Lymphoma (NHL) Treatment market has been segmented into:
Chemotherapy
Radiation Therapy
Others
By Application, B-Cell Non-Hodgkin’s Lymphoma (NHL) Treatment has been segmented into:
Hospitals
Clinics
Ambulatory Surgical Centers
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global B-Cell Non-Hodgkin’s Lymphoma (NHL) Treatment market presented in the report. This section sheds light on the sales growth of different regional and country-level B-Cell Non-Hodgkin’s Lymphoma (NHL) Treatment markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global B-Cell Non-Hodgkin’s Lymphoma (NHL) Treatment market.
The report offers in-depth assessment of the growth and other aspects of the B-Cell Non-Hodgkin’s Lymphoma (NHL) Treatment market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and B-Cell Non-Hodgkin’s Lymphoma (NHL) Treatment Market Share Analysis
B-Cell Non-Hodgkin’s Lymphoma (NHL) Treatment competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, B-Cell Non-Hodgkin’s Lymphoma (NHL) Treatment sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the B-Cell Non-Hodgkin’s Lymphoma (NHL) Treatment sales, revenue and market share for each player covered in this report.
The major players covered in B-Cell Non-Hodgkin’s Lymphoma (NHL) Treatment are:
Amgen
Novartis
Merck Serono
Bayer
AbbVie
Bristol-Myers Squibb
AstraZeneca
Roche
Among other players domestic and global, B-Cell Non-Hodgkin’s Lymphoma (NHL) Treatment market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 B-Cell Non-Hodgkin’s Lymphoma (NHL) Treatment Market Overview
1.1 Product Overview and Scope of B-Cell Non-Hodgkin’s Lymphoma (NHL) Treatment
1.2 Classification of B-Cell Non-Hodgkin’s Lymphoma (NHL) Treatment by Therapy
1.2.1 Global B-Cell Non-Hodgkin’s Lymphoma (NHL) Treatment Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global B-Cell Non-Hodgkin’s Lymphoma (NHL) Treatment Revenue Market Share by Therapy in 2019
1.2.3 Chemotherapy
1.2.4 Radiation Therapy
1.2.5 Others
1.3 Global B-Cell Non-Hodgkin’s Lymphoma (NHL) Treatment Market by End Users
1.3.1 Overview: Global B-Cell Non-Hodgkin’s Lymphoma (NHL) Treatment Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.3.5 Others
1.4 Global B-Cell Non-Hodgkin’s Lymphoma (NHL) Treatment Market by Regions
1.4.1 Global B-Cell Non-Hodgkin’s Lymphoma (NHL) Treatment Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of B-Cell Non-Hodgkin’s Lymphoma (NHL) Treatment (2015-2025)
1.4.3 North America (USA, Canada and Mexico) B-Cell Non-Hodgkin’s Lymphoma (NHL) Treatment Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) B-Cell Non-Hodgkin’s Lymphoma (NHL) Treatment Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) B-Cell Non-Hodgkin’s Lymphoma (NHL) Treatment Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) B-Cell Non-Hodgkin’s Lymphoma (NHL) Treatment Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) B-Cell Non-Hodgkin’s Lymphoma (NHL) Treatment Status and Prospect (2015-2025)
1.5 COVID-19 Outbreak: B-Cell Non-Hodgkin’s Lymphoma (NHL) Treatment Industry Impact
1.5.1 COVID-19 Potential Implications for the B-Cell Non-Hodgkin’s Lymphoma (NHL) Treatment
1.5.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on B-Cell Non-Hodgkin’s Lymphoma (NHL) Treatment
1.5.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.5.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.5.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.5.2 Opportunity Analysis in Covid-19 Crisis
1.5.3 Market Risk and Restraints
1.5.4 Market Driving Force
2 Company Profiles
2.1 Amgen
2.1.1 Amgen Details
2.1.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Amgen SWOT Analysis
2.1.4 Amgen Product and Services
2.1.5 Amgen B-Cell Non-Hodgkin’s Lymphoma (NHL) Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Novartis SWOT Analysis
2.2.4 Novartis Product and Services
2.2.5 Novartis B-Cell Non-Hodgkin’s Lymphoma (NHL) Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.3 Merck Serono
2.3.1 Merck Serono Details
2.3.2 Merck Serono Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Merck Serono SWOT Analysis
2.3.4 Merck Serono Product and Services
2.3.5 Merck Serono B-Cell Non-Hodgkin’s Lymphoma (NHL) Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.4 Bayer
2.4.1 Bayer Details
2.4.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Bayer SWOT Analysis
2.4.4 Bayer Product and Services
2.4.5 Bayer B-Cell Non-Hodgkin’s Lymphoma (NHL) Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.5 AbbVie
2.5.1 AbbVie Details
2.5.2 AbbVie Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 AbbVie SWOT Analysis
2.5.4 AbbVie Product and Services
2.5.5 AbbVie B-Cell Non-Hodgkin’s Lymphoma (NHL) Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.6 Bristol-Myers Squibb
2.6.1 Bristol-Myers Squibb Details
2.6.2 Bristol-Myers Squibb Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Bristol-Myers Squibb SWOT Analysis
2.6.4 Bristol-Myers Squibb Product and Services
2.6.5 Bristol-Myers Squibb B-Cell Non-Hodgkin’s Lymphoma (NHL) Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.7 AstraZeneca
2.7.1 AstraZeneca Details
2.7.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 AstraZeneca SWOT Analysis
2.7.4 AstraZeneca Product and Services
2.7.5 AstraZeneca B-Cell Non-Hodgkin’s Lymphoma (NHL) Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.8 Roche
2.8.1 Roche Details
2.8.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Roche SWOT Analysis
2.8.4 Roche Product and Services
2.8.5 Roche B-Cell Non-Hodgkin’s Lymphoma (NHL) Treatment Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global B-Cell Non-Hodgkin’s Lymphoma (NHL) Treatment Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 B-Cell Non-Hodgkin’s Lymphoma (NHL) Treatment Players Market Share
3.2.2 Top 10 B-Cell Non-Hodgkin’s Lymphoma (NHL) Treatment Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global B-Cell Non-Hodgkin’s Lymphoma (NHL) Treatment Revenue and Market Share by Regions
4.2 North America B-Cell Non-Hodgkin’s Lymphoma (NHL) Treatment Revenue and Growth Rate (2015-2020)
4.3 Europe B-Cell Non-Hodgkin’s Lymphoma (NHL) Treatment Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific B-Cell Non-Hodgkin’s Lymphoma (NHL) Treatment Revenue and Growth Rate (2015-2020)
4.5 South America B-Cell Non-Hodgkin’s Lymphoma (NHL) Treatment Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa B-Cell Non-Hodgkin’s Lymphoma (NHL) Treatment Revenue and Growth Rate (2015-2020)
5 North America B-Cell Non-Hodgkin’s Lymphoma (NHL) Treatment Revenue by Countries
5.1 North America B-Cell Non-Hodgkin’s Lymphoma (NHL) Treatment Revenue by Countries (2015-2020)
5.2 USA B-Cell Non-Hodgkin’s Lymphoma (NHL) Treatment Revenue and Growth Rate (2015-2020)
5.3 Canada B-Cell Non-Hodgkin’s Lymphoma (NHL) Treatment Revenue and Growth Rate (2015-2020)
5.4 Mexico B-Cell Non-Hodgkin’s Lymphoma (NHL) Treatment Revenue and Growth Rate (2015-2020)
6 Europe B-Cell Non-Hodgkin’s Lymphoma (NHL) Treatment Revenue by Countries
6.1 Europe B-Cell Non-Hodgkin’s Lymphoma (NHL) Treatment Revenue by Countries (2015-2020)
6.2 Germany B-Cell Non-Hodgkin’s Lymphoma (NHL) Treatment Revenue and Growth Rate (2015-2020)
6.3 UK B-Cell Non-Hodgkin’s Lymphoma (NHL) Treatment Revenue and Growth Rate (2015-2020)
6.4 France B-Cell Non-Hodgkin’s Lymphoma (NHL) Treatment Revenue and Growth Rate (2015-2020)
6.5 Russia B-Cell Non-Hodgkin’s Lymphoma (NHL) Treatment Revenue and Growth Rate (2015-2020)
6.6 Italy B-Cell Non-Hodgkin’s Lymphoma (NHL) Treatment Revenue and Growth Rate (2015-2020)
7 Asia-Pacific B-Cell Non-Hodgkin’s Lymphoma (NHL) Treatment Revenue by Countries
7.1 Asia-Pacific B-Cell Non-Hodgkin’s Lymphoma (NHL) Treatment Revenue by Countries (2015-2020)
7.2 China B-Cell Non-Hodgkin’s Lymphoma (NHL) Treatment Revenue and Growth Rate (2015-2020)
7.3 Japan B-Cell Non-Hodgkin’s Lymphoma (NHL) Treatment Revenue and Growth Rate (2015-2020)
7.4 Korea B-Cell Non-Hodgkin’s Lymphoma (NHL) Treatment Revenue and Growth Rate (2015-2020)
7.5 India B-Cell Non-Hodgkin’s Lymphoma (NHL) Treatment Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia B-Cell Non-Hodgkin’s Lymphoma (NHL) Treatment Revenue and Growth Rate (2015-2020)
8 South America B-Cell Non-Hodgkin’s Lymphoma (NHL) Treatment Revenue by Countries
8.1 South America B-Cell Non-Hodgkin’s Lymphoma (NHL) Treatment Revenue by Countries (2015-2020)
8.2 Brazil B-Cell Non-Hodgkin’s Lymphoma (NHL) Treatment Revenue and Growth Rate (2015-2020)
8.3 Argentina B-Cell Non-Hodgkin’s Lymphoma (NHL) Treatment Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue B-Cell Non-Hodgkin’s Lymphoma (NHL) Treatment by Countries
9.1 Middle East & Africa B-Cell Non-Hodgkin’s Lymphoma (NHL) Treatment Revenue by Countries (2015-2020)
9.2 Saudi Arabia B-Cell Non-Hodgkin’s Lymphoma (NHL) Treatment Revenue and Growth Rate (2015-2020)
9.3 UAE B-Cell Non-Hodgkin’s Lymphoma (NHL) Treatment Revenue and Growth Rate (2015-2020)
9.4 Egypt B-Cell Non-Hodgkin’s Lymphoma (NHL) Treatment Revenue and Growth Rate (2015-2020)
9.5 South Africa B-Cell Non-Hodgkin’s Lymphoma (NHL) Treatment Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global B-Cell Non-Hodgkin’s Lymphoma (NHL) Treatment Revenue and Market Share by Therapy (2015-2020)
10.2 Global B-Cell Non-Hodgkin’s Lymphoma (NHL) Treatment Market Forecast by Therapy (2019-2024)
10.3 Chemotherapy Revenue Growth Rate (2015-2025)
10.4 Radiation Therapy Revenue Growth Rate (2015-2025)
10.5 Others Revenue Growth Rate (2015-2025)
11 Global B-Cell Non-Hodgkin’s Lymphoma (NHL) Treatment Market Segment by End Users
11.1 Global B-Cell Non-Hodgkin’s Lymphoma (NHL) Treatment Revenue Market Share by End Users (2015-2020)
11.2 B-Cell Non-Hodgkin’s Lymphoma (NHL) Treatment Market Forecast by End Users (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Clinics Revenue Growth (2015-2020)
11.5 Ambulatory Surgical Centers Revenue Growth (2015-2020)
11.6 Others Revenue Growth (2015-2020)
12 Global B-Cell Non-Hodgkin’s Lymphoma (NHL) Treatment Market Size Forecast (2021-2025)
12.1 Global B-Cell Non-Hodgkin’s Lymphoma (NHL) Treatment Market Size Forecast (2021-2025)
12.2 Global B-Cell Non-Hodgkin’s Lymphoma (NHL) Treatment Market Forecast by Regions (2021-2025)
12.3 North America B-Cell Non-Hodgkin’s Lymphoma (NHL) Treatment Revenue Market Forecast (2021-2025)
12.4 Europe B-Cell Non-Hodgkin’s Lymphoma (NHL) Treatment Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific B-Cell Non-Hodgkin’s Lymphoma (NHL) Treatment Revenue Market Forecast (2021-2025)
12.6 South America B-Cell Non-Hodgkin’s Lymphoma (NHL) Treatment Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa B-Cell Non-Hodgkin’s Lymphoma (NHL) Treatment Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Amgen Corporate Information, Location and Competitors
Table 7. Amgen B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Major Business
Table 8. Amgen B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Total Revenue (USD Million) (2017-2018)
Table 9. Amgen SWOT Analysis
Table 10. Amgen B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Product and Solutions
Table 11. Amgen B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Novartis Corporate Information, Location and Competitors
Table 13. Novartis B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Major Business
Table 14. Novartis B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Total Revenue (USD Million) (2018-2019)
Table 15. Novartis SWOT Analysis
Table 16. Novartis B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Product and Solutions
Table 17. Novartis B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Merck Serono Corporate Information, Location and Competitors
Table 19. Merck Serono B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Major Business
Table 20. Merck Serono B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Total Revenue (USD Million) (2017-2018)
Table 21. Merck Serono SWOT Analysis
Table 22. Merck Serono B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Product and Solutions
Table 23. Merck Serono B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Bayer Corporate Information, Location and Competitors
Table 25. Bayer B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Major Business
Table 26. Bayer B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Total Revenue (USD Million) (2017-2018)
Table 27. Bayer SWOT Analysis
Table 28. Bayer B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Product and Solutions
Table 29. Bayer B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. AbbVie Corporate Information, Location and Competitors
Table 31. AbbVie B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Major Business
Table 32. AbbVie B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Total Revenue (USD Million) (2017-2018)
Table 33. AbbVie SWOT Analysis
Table 34. AbbVie B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Product and Solutions
Table 35. AbbVie B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Bristol-Myers Squibb Corporate Information, Location and Competitors
Table 37. Bristol-Myers Squibb B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Major Business
Table 38. Bristol-Myers Squibb B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Total Revenue (USD Million) (2017-2018)
Table 39. Bristol-Myers Squibb SWOT Analysis
Table 40. Bristol-Myers Squibb B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Product and Solutions
Table 41. Bristol-Myers Squibb B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. AstraZeneca Corporate Information, Location and Competitors
Table 43. AstraZeneca B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Major Business
Table 44. AstraZeneca B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Total Revenue (USD Million) (2017-2018)
Table 45. AstraZeneca SWOT Analysis
Table 46. AstraZeneca B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Product and Solutions
Table 47. AstraZeneca B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Roche Corporate Information, Location and Competitors
Table 49. Roche B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Major Business
Table 50. Roche B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Total Revenue (USD Million) (2017-2018)
Table 51. Roche SWOT Analysis
Table 52. Roche B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Product and Solutions
Table 53. Roche B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue (Million USD) by Players (2015-2020)
Table 55. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue Share by Players (2015-2020)
Table 56. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue (Million USD) by Regions (2015-2020)
Table 57. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue Market Share by Regions (2015-2020)
Table 58. North America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue by Countries (2015-2020)
Table 59. North America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue Market Share by Countries (2015-2020)
Table 60. Europe B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue (Million USD) by Countries (2015-2020)
Table 61. Asia-Pacific B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue (Million USD) by Countries (2015-2020)
Table 62. South America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue by Countries (2015-2020)
Table 63. South America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue Market Share by Countries (2015-2020)
Table 64. Middle East and Africa B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue (Million USD) by Countries (2015-2020)
Table 65. Middle East and Africa B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue Market Share by Countries (2015-2020)
Table 66. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue (Million USD) by Type (2015-2020)
Table 67. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue Share by Type (2015-2020)
Table 68. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue Forecast by Type (2021-2025)
Table 69. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue by Application (2015-2020)
Table 70. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue Share by Application (2015-2020)
Table 71. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue Forecast by Application (2021-2025)
Table 72. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Picture
Figure 2. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue Market Share by Therapy in 2019
Figure 3. Chemotherapy Picture
Figure 4. Radiation Therapy Picture
Figure 5. Others Picture
Figure 6. B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue Market Share by End Users in 2019
Figure 7. Hospitals Picture
Figure 8. Clinics Picture
Figure 9. Ambulatory Surgical Centers Picture
Figure 10. Others Picture
Figure 11. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue Share by Players in 2019
Figure 19. Global Top 5 Players B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue Market Share in 2019
Figure 20. Global Top 10 Players B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue Market Share by Regions (2015-2020)
Figure 24. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue Market Share by Regions in 2018
Figure 25. North America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue and Growth Rate (2015-2020)
Figure 26. Europe B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue and Growth Rate (2015-2020)
Figure 28. South America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue and Growth Rate (2015-2020)
Figure 30. North America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue Market Share by Countries (2015-2020)
Figure 31. North America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue Market Share by Countries in 2019
Figure 32. USA B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue and Growth Rate (2015-2020)
Figure 33. Canada B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue and Growth Rate (2015-2020)
Figure 34. Mexico B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue and Growth Rate (2015-2020)
Figure 35. Europe B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue Market Share by Countries (2015-2020)
Figure 36. Europe B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue Market Share by Countries in 2019
Figure 37. Germany B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue and Growth Rate (2015-2020)
Figure 38. UK B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue and Growth Rate (2015-2020)
Figure 39. France B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue and Growth Rate (2015-2020)
Figure 40. Russia B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue and Growth Rate (2015-2020)
Figure 41. Italy B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue Market Share by Countries in 2019
Figure 44. China B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue and Growth Rate (2015-2020)
Figure 45. Japan B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue and Growth Rate (2015-2020)
Figure 46. Korea B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue and Growth Rate (2015-2020)
Figure 47. India B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue and Growth Rate (2015-2020)
Figure 49. South America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue Market Share by Countries (2015-2020)
Figure 50. South America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue Market Share by Countries in 2019
Figure 51. Brazil B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue and Growth Rate (2015-2020)
Figure 52. Argentina B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue and Growth Rate (2015-2020)
Figure 56. UAE B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue and Growth Rate (2015-2020)
Figure 57. Egypt B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue and Growth Rate (2015-2020)
Figure 58. South Africa B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue and Growth Rate (2015-2020)
Figure 59. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue Share by Type (2015-2020)
Figure 60. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue Share by Type in 2019
Figure 61. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Share Forecast by Type (2021-2025)
Figure 62. Global Chemotherapy Revenue Growth Rate (2015-2020)
Figure 63. Global Radiation Therapy Revenue Growth Rate (2015-2020)
Figure 64. Global Others Revenue Growth Rate (2015-2020)
Figure 65. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue Share by Application (2015-2020)
Figure 66. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue Share by Application in 2019
Figure 67. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Share Forecast by Application (2021-2025)
Figure 68. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 69. Global Clinics Revenue Growth Rate (2015-2020)
Figure 70. Global Ambulatory Surgical Centers Revenue Growth Rate (2015-2020)
Figure 71. Global Others Revenue Growth Rate (2015-2020)
Figure 72. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue Market Forecast (2021-2025)
Figure 76. Europe B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue Market Forecast (2021-2025)
Figure 78. South America B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
非ホジキンリンパ腫治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Non-Hodgkin Lymphoma Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain opti…- 皮膚B細胞リンパ腫治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Cutaneous B-Cell Lymphoma Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain…
- 末梢T細胞リンパ腫（PTCL）治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Peripheral T-Cell Lymphoma (PTCL) Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, val…
- 皮膚T細胞リンパ腫（CTCL）治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Cutaneous T-Cell Lymphoma (CTCL) Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, valu…
- 血管免疫芽球性T細胞リンパ腫（AILT）治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Angioimmunoblastic T-Cell Lymphoma (AILT) Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market play…